 Ilana Neuberger
Concepts (142)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Imaging | 15 | 2025 | 3734 | 1.550 |
Why?
| | Palatal Muscles | 4 | 2024 | 5 | 1.240 |
Why?
| | Neuroimaging | 4 | 2025 | 278 | 1.210 |
Why?
| | Hydrocephalus | 2 | 2020 | 110 | 1.200 |
Why?
| | Megalencephaly | 2 | 2023 | 20 | 0.950 |
Why?
| | Tin | 1 | 2023 | 9 | 0.800 |
Why?
| | Epidermal Cyst | 1 | 2022 | 12 | 0.740 |
Why?
| | Dermoid Cyst | 1 | 2022 | 14 | 0.730 |
Why?
| | Migraine Disorders | 1 | 2023 | 106 | 0.710 |
Why?
| | Cleft Palate | 1 | 2022 | 81 | 0.710 |
Why?
| | Stroke | 4 | 2023 | 1199 | 0.690 |
Why?
| | White Matter | 1 | 2023 | 146 | 0.690 |
Why?
| | Glioma | 1 | 2025 | 418 | 0.680 |
Why?
| | Spinal Dysraphism | 1 | 2022 | 107 | 0.670 |
Why?
| | Abnormalities, Multiple | 1 | 2022 | 197 | 0.670 |
Why?
| | Nervous System Malformations | 1 | 2020 | 44 | 0.650 |
Why?
| | Tomography, X-Ray Computed | 4 | 2024 | 2765 | 0.640 |
Why?
| | Cerebrospinal Fluid Shunts | 1 | 2020 | 32 | 0.630 |
Why?
| | Central Nervous System Infections | 1 | 2018 | 35 | 0.540 |
Why?
| | Head and Neck Neoplasms | 1 | 2022 | 557 | 0.510 |
Why?
| | Brain Neoplasms | 1 | 2025 | 1282 | 0.480 |
Why?
| | Retrospective Studies | 17 | 2025 | 16447 | 0.470 |
Why?
| | Child | 15 | 2025 | 22390 | 0.430 |
Why?
| | Moyamoya Disease | 2 | 2024 | 21 | 0.410 |
Why?
| | Cerebral Revascularization | 2 | 2024 | 22 | 0.410 |
Why?
| | Palate, Soft | 2 | 2024 | 15 | 0.410 |
Why?
| | Prenatal Diagnosis | 3 | 2024 | 190 | 0.360 |
Why?
| | Infant | 10 | 2025 | 9820 | 0.340 |
Why?
| | Ultrasonography, Prenatal | 2 | 2024 | 291 | 0.330 |
Why?
| | Magnetic Resonance Angiography | 2 | 2024 | 248 | 0.320 |
Why?
| | Humans | 31 | 2025 | 141284 | 0.310 |
Why?
| | Brain | 5 | 2024 | 2857 | 0.270 |
Why?
| | Fetus | 2 | 2022 | 797 | 0.260 |
Why?
| | Pharynx | 2 | 2024 | 61 | 0.240 |
Why?
| | Vertebral Artery Dissection | 2 | 2022 | 29 | 0.220 |
Why?
| | Turbinates | 1 | 2024 | 14 | 0.220 |
Why?
| | Infant, Newborn | 5 | 2024 | 6270 | 0.220 |
Why?
| | Neoplasm Grading | 1 | 2025 | 311 | 0.220 |
Why?
| | Micrognathism | 1 | 2024 | 19 | 0.220 |
Why?
| | Craniopharyngioma | 1 | 2025 | 78 | 0.220 |
Why?
| | Neck | 2 | 2022 | 106 | 0.210 |
Why?
| | Polymicrogyria | 1 | 2023 | 6 | 0.200 |
Why?
| | Hypoxia-Ischemia, Brain | 1 | 2024 | 41 | 0.200 |
Why?
| | Pituitary Neoplasms | 1 | 2025 | 194 | 0.200 |
Why?
| | Circle of Willis | 1 | 2022 | 7 | 0.190 |
Why?
| | Pregnancy | 4 | 2024 | 7035 | 0.180 |
Why?
| | Headache | 1 | 2023 | 153 | 0.180 |
Why?
| | Radiation Dosage | 1 | 2023 | 189 | 0.180 |
Why?
| | Intracranial Aneurysm | 1 | 2022 | 100 | 0.170 |
Why?
| | Sensitivity and Specificity | 3 | 2025 | 1973 | 0.170 |
Why?
| | Female | 17 | 2025 | 75814 | 0.170 |
Why?
| | Spine | 1 | 2022 | 179 | 0.170 |
Why?
| | Sex Factors | 2 | 2024 | 2055 | 0.170 |
Why?
| | Leukodystrophy, Globoid Cell | 1 | 2020 | 8 | 0.160 |
Why?
| | Craniocerebral Trauma | 1 | 2022 | 175 | 0.160 |
Why?
| | Ventriculoperitoneal Shunt | 1 | 2020 | 40 | 0.160 |
Why?
| | Spinal Cord | 1 | 2022 | 374 | 0.160 |
Why?
| | Infant, Premature | 1 | 2024 | 599 | 0.150 |
Why?
| | Child, Preschool | 6 | 2025 | 11511 | 0.150 |
Why?
| | Age Factors | 2 | 2024 | 3295 | 0.150 |
Why?
| | Sturge-Weber Syndrome | 1 | 2018 | 2 | 0.150 |
Why?
| | Thrombosis | 1 | 2022 | 399 | 0.140 |
Why?
| | Toxoplasmosis | 1 | 2018 | 43 | 0.140 |
Why?
| | Autism Spectrum Disorder | 1 | 2023 | 418 | 0.130 |
Why?
| | Brain Diseases | 1 | 2018 | 150 | 0.130 |
Why?
| | Herpes Simplex | 1 | 2018 | 94 | 0.130 |
Why?
| | Chordoma | 1 | 2017 | 17 | 0.130 |
Why?
| | Skull Base Neoplasms | 1 | 2017 | 31 | 0.130 |
Why?
| | Tuberous Sclerosis | 1 | 2017 | 55 | 0.130 |
Why?
| | Child Abuse | 1 | 2022 | 548 | 0.120 |
Why?
| | Cytomegalovirus Infections | 1 | 2018 | 197 | 0.120 |
Why?
| | Acute Kidney Injury | 1 | 2024 | 822 | 0.120 |
Why?
| | Zika Virus Infection | 1 | 2018 | 165 | 0.120 |
Why?
| | Adolescent | 6 | 2025 | 22116 | 0.120 |
Why?
| | Male | 13 | 2025 | 70140 | 0.110 |
Why?
| | Prevalence | 4 | 2024 | 2795 | 0.110 |
Why?
| | Cephalometry | 2 | 2024 | 31 | 0.110 |
Why?
| | Software | 1 | 2020 | 675 | 0.110 |
Why?
| | Hyoscyamine | 1 | 2014 | 1 | 0.110 |
Why?
| | Peristalsis | 1 | 2014 | 30 | 0.110 |
Why?
| | Diagnosis, Differential | 1 | 2018 | 1491 | 0.100 |
Why?
| | Intestine, Small | 1 | 2014 | 157 | 0.100 |
Why?
| | Biomarkers | 1 | 2024 | 4180 | 0.100 |
Why?
| | Magnetic Resonance Imaging, Cine | 1 | 2014 | 209 | 0.090 |
Why?
| | Cross-Sectional Studies | 1 | 2023 | 5653 | 0.090 |
Why?
| | Observer Variation | 2 | 2025 | 356 | 0.080 |
Why?
| | Gestational Age | 2 | 2024 | 952 | 0.080 |
Why?
| | Inflammatory Bowel Diseases | 1 | 2014 | 360 | 0.070 |
Why?
| | Risk Factors | 1 | 2022 | 10490 | 0.070 |
Why?
| | Cystadenoma, Serous | 1 | 2007 | 18 | 0.060 |
Why?
| | Neoplasms, Cystic, Mucinous, and Serous | 1 | 2007 | 26 | 0.060 |
Why?
| | Extracellular Matrix Proteins | 1 | 2007 | 156 | 0.060 |
Why?
| | Nasal Septum | 1 | 2024 | 25 | 0.050 |
Why?
| | Jaw | 1 | 2024 | 26 | 0.050 |
Why?
| | Anatomic Landmarks | 1 | 2024 | 30 | 0.050 |
Why?
| | Hepatitis A Virus Cellular Receptor 1 | 1 | 2024 | 42 | 0.050 |
Why?
| | Lipocalin-2 | 1 | 2024 | 79 | 0.050 |
Why?
| | Skull | 1 | 2024 | 146 | 0.050 |
Why?
| | Hypothermia, Induced | 1 | 2024 | 92 | 0.050 |
Why?
| | HIV Infections | 1 | 2018 | 2981 | 0.050 |
Why?
| | Reproducibility of Results | 2 | 2025 | 3345 | 0.050 |
Why?
| | Hematoma, Subdural | 1 | 2022 | 20 | 0.050 |
Why?
| | Interleukin-18 | 1 | 2024 | 236 | 0.050 |
Why?
| | Contrast Media | 1 | 2025 | 476 | 0.050 |
Why?
| | Adult | 2 | 2023 | 39319 | 0.050 |
Why?
| | Vertebral Artery | 1 | 2022 | 27 | 0.050 |
Why?
| | PTEN Phosphohydrolase | 1 | 2023 | 162 | 0.050 |
Why?
| | Treatment Outcome | 3 | 2024 | 11216 | 0.050 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2023 | 364 | 0.040 |
Why?
| | Arteries | 1 | 2023 | 260 | 0.040 |
Why?
| | Ovarian Neoplasms | 1 | 2007 | 581 | 0.040 |
Why?
| | Multivariate Analysis | 1 | 2024 | 1505 | 0.040 |
Why?
| | Prenatal Care | 1 | 2022 | 301 | 0.040 |
Why?
| | Carotid Artery Diseases | 1 | 2019 | 62 | 0.040 |
Why?
| | Sex Characteristics | 1 | 2024 | 783 | 0.040 |
Why?
| | Recurrence | 1 | 2022 | 1108 | 0.040 |
Why?
| | Rhabdomyoma | 1 | 2017 | 7 | 0.030 |
Why?
| | Angiomyolipoma | 1 | 2017 | 22 | 0.030 |
Why?
| | Heart Neoplasms | 1 | 2017 | 55 | 0.030 |
Why?
| | Imaging, Three-Dimensional | 1 | 2019 | 565 | 0.030 |
Why?
| | Tumor Suppressor Proteins | 1 | 2017 | 325 | 0.030 |
Why?
| | Neoplasm Metastasis | 1 | 2017 | 674 | 0.030 |
Why?
| | Administration, Sublingual | 1 | 2014 | 12 | 0.030 |
Why?
| | Antidiarrheals | 1 | 2014 | 14 | 0.030 |
Why?
| | Muscarinic Antagonists | 1 | 2014 | 30 | 0.030 |
Why?
| | Kidney Neoplasms | 1 | 2017 | 400 | 0.020 |
Why?
| | Disease Progression | 1 | 2020 | 2808 | 0.020 |
Why?
| | Postoperative Complications | 1 | 2024 | 2831 | 0.020 |
Why?
| | Prospective Studies | 1 | 2024 | 7805 | 0.020 |
Why?
| | Skin Neoplasms | 1 | 2017 | 851 | 0.020 |
Why?
| | Young Adult | 1 | 2024 | 13727 | 0.020 |
Why?
| | Syndecan-1 | 1 | 2007 | 41 | 0.020 |
Why?
| | Collagen Type IV | 1 | 2007 | 28 | 0.020 |
Why?
| | Laminin | 1 | 2007 | 72 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2014 | 2904 | 0.010 |
Why?
| | Membrane Glycoproteins | 1 | 2007 | 490 | 0.010 |
Why?
| | Lung Neoplasms | 1 | 2017 | 2554 | 0.010 |
Why?
| | United States | 1 | 2019 | 15298 | 0.010 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2007 | 1439 | 0.010 |
Why?
| | Biomarkers, Tumor | 1 | 2007 | 1250 | 0.010 |
Why?
| | Aged | 1 | 2019 | 24836 | 0.010 |
Why?
| | Middle Aged | 1 | 2019 | 34658 | 0.010 |
Why?
|
|
Neuberger's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|